Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
17%
Ph not_applicable
4
67%
Ph phase_4
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Other(2)

Detailed Status

Completed3
unknown2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (16.7%)
Phase 41 (16.7%)
N/A4 (66.7%)

Trials by Status

unknown233%
enrolling_by_invitation117%
completed350%

Recent Activity

0 active trials
Showing 5 of 6
enrolling_by_invitationnot_applicable

Effect of Triple Versus Quadruple Therapy for Treating Helicobacter Pylori Infection

NCT07010744
completedphase_4

Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis

NCT07312721
unknownnot_applicable

Empirical vs Tailored Therapy for H. Pylori Infection

NCT04006340
unknownphase_3

A Unique Regimen for Treatment of Helicobacter Pylori Infection

NCT03491995
completednot_applicable

Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication

NCT01306786
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07010744Not Applicable

Effect of Triple Versus Quadruple Therapy for Treating Helicobacter Pylori Infection

Enrolling By Invitation
NCT07312721Phase 4

Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis

Completed
NCT04006340Not Applicable

Empirical vs Tailored Therapy for H. Pylori Infection

Unknown
NCT03491995Phase 3

A Unique Regimen for Treatment of Helicobacter Pylori Infection

Unknown
NCT01306786Not Applicable

Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication

Completed
NCT01760824Not Applicable

Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6